Serum Institute of India Current Affairs, GK & News

PM Takes First Dose of COVID-19 Vaccine

The Prime Minister of India, Narendra Modi, takes first dose of COVID-19 vaccine on March 1, 2021 at AIIMS, New Delhi. After vaccination, he appealed to those people who are eligible to get their vaccination done. Covid-19 Vaccination in India The national vaccination programme to for the virus called “SARS-CoV-2” which has caused ongoing Covid-19 ..

Month: 

Category: 

Topics: 

COVID-19 Vaccination Phase 2 to begin from March 1

The Union Government has announced that the second phase of COVID-19 vaccination will begin from March 1, 2021. Highlights Under the second phase of covid-19 vaccination, people aged above 60 years will get vaccinated. Further, as per the guidelines, those aged above 45 years and are having comorbidities (that means presence of one or more ..

Month: 

Category: 

Topics: 

SII’s Covishield gets emergency-use nod from DGCI

The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..

Month: 

Category: 

Topics: 

Pneumosil: India’s First Pneumonia Vaccine

The Serum Institute of India recently unveiled the first indigenously developed Pneumococcal Vaccine called Pneumosil. The vaccine was launched by the Union Health Minister Harsh Vardhan. About the Vaccine Pneumosil was developed through collaboration with Bill and Melinda Gates Foundation and PATH organization. It has been approved by the Drugs Controller General of India. The ..

Month: 

Category: 

Topics: 

India’s First Indigenous Vaccine against Pneumonia

The first Indian vaccine against Pneumonia has been developed by Serum Institute of India. The vaccine is to be made available to the domestic makers soon. Highlights India has access to pneumonia vaccines. However, the new locally developed vaccine is much cheaper than the other pneumonia vaccines such as NYSE:PFE produced by Pfizer and LSE:GSK ..

Month: 

Category: 

Topics: 

1 / 3123